On the public citation graph

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

https://doi.org/10.1073/pnas.1200566109
0 signed · 428 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1006/viro.1995.1374openalex-snapshot
Murray Valley Encephalitis Virus Envelope Protein Antigenic Variants with Altered Hemagglutination Properties and Reduced Neuroinvasiveness in Mice
inferredcites →https://doi.org/10.1016/j.chom.2010.08.007openalex-snapshot
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
inferredcites →https://doi.org/10.1016/j.str.2011.02.012openalex-snapshot
Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120
inferredcites →https://doi.org/10.1016/j.vaccine.2011.06.101openalex-snapshot
Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses
inferredcites →https://doi.org/10.1016/j.vaccine.2011.07.020openalex-snapshot
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
inferredcites →https://doi.org/10.1016/j.vaccine.2011.07.021openalex-snapshot
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
inferredcites →https://doi.org/10.1016/j.virol.2006.08.047openalex-snapshot
The neutralizing antibody response against West Nile virus in naturally infected horses
inferredcites →https://doi.org/10.1016/j.virol.2007.05.042openalex-snapshot
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
inferredcites →https://doi.org/10.1016/j.virol.2009.06.037openalex-snapshot
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
inferredcites →https://doi.org/10.1016/j.virol.2010.06.044openalex-snapshot
Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape
inferredcites →https://doi.org/10.1016/s0065-3527(03)59005-4openalex-snapshot
Antigenic Structure of Flavivirus Proteins
inferredcites →https://doi.org/10.1016/s0065-3527(03)60011-4openalex-snapshot
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
inferredcites →https://doi.org/10.1016/s0092-8674(02)00660-8openalex-snapshot
Structure of Dengue Virus
inferredcites →https://doi.org/10.1038/375291a0openalex-snapshot
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
inferredcites →https://doi.org/10.1038/nm1144openalex-snapshot
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
inferredcites →https://doi.org/10.1038/nsb990openalex-snapshot
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
inferredcites →https://doi.org/10.1038/nsmb.1382openalex-snapshot
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
inferredcites →https://doi.org/10.1038/nsmb.2150openalex-snapshot
A shared structural solution for neutralizing ebolaviruses
inferredcites →https://doi.org/10.1073/pnas.0832193100openalex-snapshot
A ligand-binding pocket in the dengue virus envelope glycoprotein
inferredcites →https://doi.org/10.1073/pnas.1011036107openalex-snapshot
Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354
inferredcites →https://doi.org/10.1089/vim.2007.0050openalex-snapshot
Antibody to Dengue 1 Detected More Than 60 Years after Infection
inferredcites →https://doi.org/10.1126/science.1153263openalex-snapshot
The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation
inferredcites →https://doi.org/10.1126/science.1185181openalex-snapshot
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
inferredcites →https://doi.org/10.1128/cvi.00382-10openalex-snapshot
The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
inferredcites →https://doi.org/10.1128/jcm.00827-07openalex-snapshot
Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization
inferredcites →https://doi.org/10.1128/jvi.00286-09openalex-snapshot
Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step
inferredcites →https://doi.org/10.1128/jvi.00291-08openalex-snapshot
Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo
inferredcites →https://doi.org/10.1128/jvi.00432-07openalex-snapshot
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
inferredcites →https://doi.org/10.1128/jvi.00643-07openalex-snapshot
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus
inferredcites →https://doi.org/10.1128/jvi.01087-10openalex-snapshot
Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
inferredcites →https://doi.org/10.1128/jvi.01125-06openalex-snapshot
Crystal Structure of the West Nile Virus Envelope Glycoprotein
inferredcites →https://doi.org/10.1128/jvi.01190-10openalex-snapshot
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
inferredcites →https://doi.org/10.1128/jvi.01732-06openalex-snapshot
Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein
inferredcites →https://doi.org/10.1128/jvi.06335-11openalex-snapshot
Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
inferredcites →https://doi.org/10.1128/jvi.06871-11openalex-snapshot
Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera
inferredcites →https://doi.org/10.1128/jvi.79.2.1223-1231.2005openalex-snapshot
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
inferredcites →https://doi.org/10.1142/9781848162297_0002openalex-snapshot
The Infectious Agent
inferredcites →https://doi.org/10.1371/journal.pntd.0001188openalex-snapshot
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
inferredcites →https://doi.org/10.1371/journal.ppat.1000821openalex-snapshot
Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
inferredcites →https://doi.org/10.1371/journal.ppat.1000823openalex-snapshot
The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3574666openalex-extracted
Stimulation of B Cell Immunity in Flavivirus-Naïve Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003
inferred← citeshttps://doi.org/10.1002/adtp.202500422openalex-snapshot
Therapeutic Antibodies for Mosquito‐Borne Orthoflavivirus Infections: Discovery, Engineering Approaches, and Advances in mRNA‐Based Delivery Systems
inferred← citeshttps://doi.org/10.1002/emmm.201303404openalex-snapshot
A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
inferred← citeshttps://doi.org/10.1002/jmv.70100openalex-snapshot
Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil
inferred← citeshttps://doi.org/10.1002/prca.201600002openalex-snapshot
Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display
inferred← citeshttps://doi.org/10.1002/prot.24745openalex-snapshot
Key mutations stabilize antigen‐binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage
inferred← citeshttps://doi.org/10.1002/rmv.2100openalex-snapshot
The role of anti‐flavivirus humoral immune response in protection and pathogenesis
inferred← citeshttps://doi.org/10.1007/978-1-4939-3670-0_19openalex-snapshot
An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection
inferred← citeshttps://doi.org/10.1007/978-3-319-22473-2_4openalex-snapshot
Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-32805-8_4openalex-snapshot
Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy
inferred← citeshttps://doi.org/10.1007/978-981-10-4857-9_18-1openalex-snapshot
The Art of Therapeutic Antibody Discovery: Finding Them One Cell at a Time
inferred← citeshttps://doi.org/10.1007/978-981-10-8727-1_5openalex-snapshot
The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections
inferred← citeshttps://doi.org/10.1007/978-981-10-8953-4_18openalex-snapshot
The Art of Therapeutic Antibody Discovery: Finding Them One Cell at a Time
inferred← citeshttps://doi.org/10.1007/978-981-16-8702-0_11openalex-snapshot
Flavivirus Entry Inhibitors
inferred← citeshttps://doi.org/10.1007/s00216-020-03091-9openalex-snapshot
Research advances in hydrogen–deuterium exchange mass spectrometry for protein epitope mapping
inferred← citeshttps://doi.org/10.1007/s00253-015-6538-9openalex-snapshot
Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM
inferred← citeshttps://doi.org/10.1007/s00430-021-00726-1openalex-snapshot
Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics
inferred← citeshttps://doi.org/10.1007/s00705-013-1639-1openalex-snapshot
A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
inferred← citeshttps://doi.org/10.1007/s11908-014-0404-2openalex-snapshot
Dengue: Challenges for Policy Makers and Vaccine Developers
inferred← citeshttps://doi.org/10.1007/s12013-023-01175-8openalex-snapshot
Computer-aided Affinity Enhancement of a Cross-reactive Antibody against Dengue Virus Envelope Domain III
inferred← citeshttps://doi.org/10.1007/s12033-014-9787-4openalex-snapshot
Dengue Virus E Glycoprotein Production in Transgenic Rice Callus
inferred← citeshttps://doi.org/10.1007/s12250-018-0030-5openalex-snapshot
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
inferred← citeshttps://doi.org/10.1007/s12275-017-6494-4openalex-snapshot
Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses
inferred← citeshttps://doi.org/10.1016/b978-0-12-800098-4.00007-6openalex-snapshot
Dengue Virus Vaccine Development
inferred← citeshttps://doi.org/10.1016/b978-0-12-815422-9.00014-0openalex-snapshot
Dengue Virus Polymerase
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00017-1openalex-snapshot
Dengue Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00019-0openalex-snapshot
Dengue Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00184-9openalex-snapshot
Dengue, Dengue Hemorrhagic Fever, and Severe Dengue
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2014.10.005openalex-snapshot
A Game of Numbers
inferred← citeshttps://doi.org/10.1016/j.actatropica.2017.04.006openalex-snapshot
Construct and expression of recombinant domains I/II of dengue virus- 2 and its efficacy to evaluate immune response in endemic area: Possible use in prognosis
inferred← citeshttps://doi.org/10.1016/j.amepre.2015.09.006openalex-snapshot
Trials and Tribulations on the Path to Developing a Dengue Vaccine
inferred← citeshttps://doi.org/10.1016/j.antiviral.2012.09.018openalex-snapshot
Neutralization of dengue virus in the presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from cross-neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.antiviral.2013.03.018openalex-snapshot
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
inferred← citeshttps://doi.org/10.1016/j.antiviral.2016.01.002openalex-snapshot
The development of therapeutic antibodies against dengue virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2019.104554openalex-snapshot
Altered monocyte response to the dengue virus in those with varying severity of past dengue infection
inferred← citeshttps://doi.org/10.1016/j.bbrc.2014.02.131openalex-snapshot
Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus
inferred← citeshttps://doi.org/10.1016/j.bbrc.2016.03.146openalex-snapshot
Development of a monoclonal antibody specific to envelope domain III with broad-spectrum detection of all four dengue virus serotypes
inferred← citeshttps://doi.org/10.1016/j.biologicals.2018.10.003openalex-snapshot
Human single-chain variable fragment antibody expressed in E. coli with optimal in vitro cross-neutralizing and no enhancing activity
inferred← citeshttps://doi.org/10.1016/j.cell.2015.06.057openalex-snapshot
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope
inferred← citeshttps://doi.org/10.1016/j.cell.2015.07.005openalex-snapshot
Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control
inferred← citeshttps://doi.org/10.1016/j.cell.2016.07.020openalex-snapshot
Structural Basis of Zika Virus-Specific Antibody Protection
inferred← citeshttps://doi.org/10.1016/j.cell.2017.09.002openalex-snapshot
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.10.006openalex-snapshot
Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.12.065openalex-snapshot
Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.02.062openalex-snapshot
Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody
inferred← citeshttps://doi.org/10.1016/j.celrep.2020.107642openalex-snapshot
Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.111807openalex-snapshot
Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines
inferred← citeshttps://doi.org/10.1016/j.chom.2017.07.013openalex-snapshot
Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design
inferred← citeshttps://doi.org/10.1016/j.chom.2019.12.003openalex-snapshot
Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding
inferred← citeshttps://doi.org/10.1016/j.chom.2020.04.007openalex-snapshot
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies
inferred← citeshttps://doi.org/10.1016/j.chom.2020.12.011openalex-snapshot
Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection
inferred← citeshttps://doi.org/10.1016/j.chom.2021.12.009openalex-snapshot
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies
inferred← citeshttps://doi.org/10.1016/j.chom.2022.01.011openalex-snapshot
Even old foes can learn sweet new tricks
inferred← citeshttps://doi.org/10.1016/j.chom.2023.10.004openalex-snapshot
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination
inferred← citeshttps://doi.org/10.1016/j.chom.2023.10.014openalex-snapshot
Putting the pieces together: Chimeric virus strategy decode Dengue virus 3 antibody responses
inferred← citeshttps://doi.org/10.1016/j.clinthera.2017.07.001openalex-snapshot
Progress and Works in Progress: Update on Flavivirus Vaccine Development
inferred← citeshttps://doi.org/10.1016/j.coviro.2020.08.006openalex-snapshot
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus
inferred← citeshttps://doi.org/10.1016/j.ebiom.2016.09.003openalex-snapshot
Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool
inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.02.060openalex-snapshot
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model
inferred← citeshttps://doi.org/10.1016/j.ebiom.2020.102733openalex-snapshot
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104875openalex-snapshot
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.07.028openalex-snapshot
Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design
inferred← citeshttps://doi.org/10.1016/j.immuni.2022.04.010openalex-snapshot
Inducing broad-based immunity against viruses with pandemic potential
inferred← citeshttps://doi.org/10.1016/j.immuni.2024.05.002openalex-snapshot
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface
inferred← citeshttps://doi.org/10.1016/j.isci.2019.02.012openalex-snapshot
Key Amino Acid Substitution for Infection-Enhancing Activity-Free Designer Dengue Vaccines
inferred← citeshttps://doi.org/10.1016/j.isci.2021.102482openalex-snapshot
CD27hiCD38hi plasmablasts are activated B cells of mixed origin with distinct function
inferred← citeshttps://doi.org/10.1016/j.isci.2024.110899openalex-snapshot
Emergence and increased epidemic potential of dengue variants with the NS5V357E mutation after consecutive years of transmission
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102079openalex-snapshot
A conserved set of mutations for stabilizing soluble envelope protein dimers from dengue and Zika viruses to advance the development of subunit vaccines
inferred← citeshttps://doi.org/10.1016/j.jcv.2012.08.024openalex-snapshot
Flaviviruses and their antigenic structure
inferred← citeshttps://doi.org/10.1016/j.jcv.2014.08.031openalex-snapshot
Advances in the understanding, management, and prevention of dengue
inferred← citeshttps://doi.org/10.1016/j.jim.2018.07.010openalex-snapshot
Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
inferred← citeshttps://doi.org/10.1016/j.meegid.2014.09.002openalex-snapshot
Continuous dengue type 1 virus genotype shifts followed by co-circulation, clade shifts and subsequent disappearance in Surabaya, Indonesia, 2008–2013
inferred← citeshttps://doi.org/10.1016/j.meegid.2015.11.002openalex-snapshot
Divergence of the dengue virus type 2 Cosmopolitan genotype associated with two predominant serotype shifts between 1 and 2 in Surabaya, Indonesia, 2008–2014
inferred← citeshttps://doi.org/10.1016/j.micinf.2013.06.002openalex-snapshot
Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III
inferred← citeshttps://doi.org/10.1016/j.molimm.2015.12.002openalex-snapshot
Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations
inferred← citeshttps://doi.org/10.1016/j.str.2017.07.007openalex-snapshot
Epitope and Paratope Mapping Reveals Temperature-Dependent Alterations in the Dengue-Antibody Interface
inferred← citeshttps://doi.org/10.1016/j.str.2018.12.006openalex-snapshot
Infectivity of Dengue Virus Serotypes 1 and 2 Is Correlated with E-Protein Intrinsic Dynamics but Not to Envelope Conformations
inferred← citeshttps://doi.org/10.1016/j.str.2024.08.022openalex-snapshot
Discovery and characterization of a pan-betacoronavirus S2-binding antibody
inferred← citeshttps://doi.org/10.1016/j.tim.2015.12.004openalex-snapshot
The Interplay of Dengue Virus Morphological Diversity and Human Antibodies
inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.06.079openalex-snapshot
Identifying protective dengue vaccines: Guide to mastering an empirical process
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.05.095openalex-snapshot
Trials and tribulations on the path to developing a dengue vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.09.053openalex-snapshot
Next generation dengue vaccines: A review of the preclinical development pipeline
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.09.108openalex-snapshot
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.03.108openalex-snapshot
Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.07.045openalex-snapshot
Immune correlates of protection for dengue: State of the art and research agenda
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.03.055openalex-snapshot
Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.04.065openalex-snapshot
Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.10.072openalex-snapshot
Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature
inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.03.003openalex-snapshot
E. coli production process yields stable dengue 1 virus-sized particles (VSPs)
inferred← citeshttps://doi.org/10.1016/j.virol.2013.01.018openalex-snapshot
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity
inferred← citeshttps://doi.org/10.1016/j.virol.2015.03.025openalex-snapshot
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host
inferred← citeshttps://doi.org/10.1016/j.virol.2016.03.024openalex-snapshot
Characterization of dengue virus 2 growth in megakaryocyte–erythrocyte progenitor cells
inferred← citeshttps://doi.org/10.1016/j.virol.2018.03.002openalex-snapshot
Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity
inferred← citeshttps://doi.org/10.1016/j.virol.2022.09.007openalex-snapshot
A human monoclonal antibody to neutralize all four serotypes of dengue virus derived from patients at the convalescent phase of infection
inferred← citeshttps://doi.org/10.1016/j.virol.2023.109883openalex-snapshot
Activity of domain III-specific antibodies in early convalescence: A case study
inferred← citeshttps://doi.org/10.1016/j.virusres.2017.04.018openalex-snapshot
Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.virusres.2017.06.019openalex-snapshot
Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure
inferred← citeshttps://doi.org/10.1016/j.virusres.2020.198278openalex-snapshot
A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the E protein: a possible explanation of dengue virus evolution regarding the acquisition of N-67 glycan
inferred← citeshttps://doi.org/10.1016/j.virusres.2022.199015openalex-snapshot
A group of infection-enhancing and focus size-reducing monoclonal antibodies recognized an ‘a and c’ strands epitope in the pr domain of Dengue Virus prM
inferred← citeshttps://doi.org/10.1016/j.xcrm.2020.100155openalex-snapshot
Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003
inferred← citeshttps://doi.org/10.1016/j.yjsbx.2020.100028openalex-snapshot
A complex between the Zika virion and the Fab of a broadly cross-reactive neutralizing monoclonal antibody revealed by cryo-EM and single particle analysis at 4.1 Å resolution
inferred← citeshttps://doi.org/10.1016/s0140-6736(12)61428-7openalex-snapshot
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
inferred← citeshttps://doi.org/10.1016/s0140-6736(12)61510-4openalex-snapshot
Dengue vaccine development: a 75% solution?
inferred← citeshttps://doi.org/10.1016/s0140-6736(14)60572-9openalex-snapshot
Dengue
inferred← citeshttps://doi.org/10.1016/s0140-6736(14)61142-9openalex-snapshot
Dengue vaccines: dawning at last?
inferred← citeshttps://doi.org/10.1016/s1473-3099(16)30473-xopenalex-snapshot
Dengue: knowledge gaps, unmet needs, and research priorities
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.8b00090openalex-snapshot
Optimization of Surface Display of DENV2 E Protein on a Nanoparticle to Induce Virus Specific Neutralizing Antibody Responses
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01653openalex-snapshot
The Medicinal Chemistry of Dengue Virus
inferred← citeshttps://doi.org/10.1021/acsinfecdis.4c00058openalex-snapshot
An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies
inferred← citeshttps://doi.org/10.1021/acsinfecdis.5c00205openalex-snapshot
A High-Affinity and Potently Neutralized Nanobody against Zika Virus
inferred← citeshttps://doi.org/10.1021/acsinfecdis.8b00185openalex-snapshot
Impact of Dengue Virus Serotype 2 Strain Diversity on Serological Immune Responses to Dengue
inferred← citeshttps://doi.org/10.1038/497443aopenalex-snapshot
Two hosts, two structures
inferred← citeshttps://doi.org/10.1038/524295aopenalex-snapshot
Bumps in the road to therapeutic antibodies
inferred← citeshttps://doi.org/10.1038/emi.2017.42openalex-snapshot
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
inferred← citeshttps://doi.org/10.1038/emi.2017.79openalex-snapshot
Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
inferred← citeshttps://doi.org/10.1038/nature14130openalex-snapshot
Recognition determinants of broadly neutralizing human antibodies against dengue viruses
inferred← citeshttps://doi.org/10.1038/ncomms15411openalex-snapshot
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
inferred← citeshttps://doi.org/10.1038/ncomms7341openalex-snapshot
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
inferred← citeshttps://doi.org/10.1038/ni.3058openalex-snapshot
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
inferred← citeshttps://doi.org/10.1038/ni.3081openalex-snapshot
Broad and strong: the ultimate antibody to dengue virus
inferred← citeshttps://doi.org/10.1038/nri3285openalex-snapshot
Tools to therapeutically harness the human antibody response
inferred← citeshttps://doi.org/10.1038/nri3916openalex-snapshot
New insights into the immunopathology and control of dengue virus infection
inferred← citeshttps://doi.org/10.1038/nrmicro.2015.2openalex-snapshot
Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
inferred← citeshttps://doi.org/10.1038/s41426-018-0132-zopenalex-snapshot
Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection
inferred← citeshttps://doi.org/10.1038/s41467-018-07667-zopenalex-snapshot
Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection
inferred← citeshttps://doi.org/10.1038/s41467-019-08845-3openalex-snapshot
Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika
inferred← citeshttps://doi.org/10.1038/s41467-019-12677-6openalex-snapshot
Oligomeric state of the ZIKV E protein defines protective immune responses
inferred← citeshttps://doi.org/10.1038/s41467-021-21384-0openalex-snapshot
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans
inferred← citeshttps://doi.org/10.1038/s41467-025-64210-7openalex-snapshot
Ultrapotent human antibodies lock E protein dimers central region of diverse DENV3 morphological variants
inferred← citeshttps://doi.org/10.1038/s41541-016-0003-3openalex-snapshot
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
inferred← citeshttps://doi.org/10.1038/s41541-018-0077-1openalex-snapshot
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen
inferred← citeshttps://doi.org/10.1038/s41541-021-00339-yopenalex-snapshot
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques
inferred← citeshttps://doi.org/10.1038/s41541-023-00788-7openalex-snapshot
The dengue-specific immune response and antibody identification with machine learning
inferred← citeshttps://doi.org/10.1038/s41541-026-01400-4openalex-snapshot
From promise to pitfalls: immunological lessons from dengue vaccines and their implications
inferred← citeshttps://doi.org/10.1038/s41564-018-0283-7openalex-snapshot
A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions
inferred← citeshttps://doi.org/10.1038/s41564-023-01421-yopenalex-snapshot
Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice
inferred← citeshttps://doi.org/10.1038/s41564-024-01668-zopenalex-snapshot
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study
inferred← citeshttps://doi.org/10.1038/s41564-025-02153-xopenalex-snapshot
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B
inferred← citeshttps://doi.org/10.1038/s41586-024-07385-1openalex-snapshot
Computationally restoring the potency of a clinical antibody against Omicron
inferred← citeshttps://doi.org/10.1038/s41590-017-0007-9openalex-snapshot
Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic
inferred← citeshttps://doi.org/10.1038/s41590-018-0227-7openalex-snapshot
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus
inferred← citeshttps://doi.org/10.1038/s41590-018-0233-9openalex-snapshot
Antibody-mediated protection against Ebola virus
inferred← citeshttps://doi.org/10.1038/s41590-019-0477-zopenalex-snapshot
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
inferred← citeshttps://doi.org/10.1038/s41598-017-01097-5openalex-snapshot
Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells
inferred← citeshttps://doi.org/10.1038/s41598-017-04767-6openalex-snapshot
In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
inferred← citeshttps://doi.org/10.1038/s41598-017-17355-5openalex-snapshot
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
inferred← citeshttps://doi.org/10.1038/s41598-019-52511-zopenalex-snapshot
Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas
inferred← citeshttps://doi.org/10.1038/s41598-021-92403-9openalex-snapshot
An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
inferred← citeshttps://doi.org/10.1038/s42003-023-05661-wopenalex-snapshot
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
inferred← citeshttps://doi.org/10.1039/c5ib00169bopenalex-snapshot
Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing
inferred← citeshttps://doi.org/10.1073/pnas.1310962110openalex-snapshot
Atomic-level functional model of dengue virus Envelope protein infectivity
inferred← citeshttps://doi.org/10.1073/pnas.1317350111openalex-snapshot
RETRACTED: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
inferred← citeshttps://doi.org/10.1073/pnas.1323188111openalex-snapshot
Human antibodies stop dengue virus by jamming its mechanics
inferred← citeshttps://doi.org/10.1073/pnas.1607931113openalex-snapshot
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
inferred← citeshttps://doi.org/10.1073/pnas.1714250115openalex-snapshot
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials
inferred← citeshttps://doi.org/10.1073/pnas.1812055115openalex-snapshot
Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies
inferred← citeshttps://doi.org/10.1074/jbc.ra118.002658openalex-snapshot
Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins
inferred← citeshttps://doi.org/10.1080/14712598.2017.1356284openalex-snapshot
Working towards dengue as a vaccine-preventable disease: challenges and opportunities
inferred← citeshttps://doi.org/10.1080/14760584.2019.1562909openalex-snapshot
Next generation designer virus-like particle vaccines for dengue
inferred← citeshttps://doi.org/10.1080/14787210.2017.1254550openalex-snapshot
The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis
inferred← citeshttps://doi.org/10.1080/21645515.2016.1183857openalex-snapshot
Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection
inferred← citeshttps://doi.org/10.1080/21645515.2016.1261770openalex-snapshot
Vaccines licensed and in clinical trials for the prevention of dengue
inferred← citeshttps://doi.org/10.1080/21645515.2017.1322747openalex-snapshot
Detection, phenotyping and quantification of dengue virus-specific B cells using fluorescent probes
inferred← citeshttps://doi.org/10.1080/21645515.2019.1643676openalex-snapshot
Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
inferred← citeshttps://doi.org/10.1080/21645515.2021.1884473openalex-snapshot
Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models
inferred← citeshttps://doi.org/10.1080/22221751.2020.1797540openalex-snapshot
Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections
inferred← citeshttps://doi.org/10.1084/jem.20151960openalex-snapshot
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
inferred← citeshttps://doi.org/10.1089/vim.2012.0102openalex-snapshot
Serotype-Specific Anti-Dengue Virus NS1 Mouse Antibodies Cross-React with prM and Are Potentially Involved in Virus Production
inferred← citeshttps://doi.org/10.1093/cid/ciab282openalex-snapshot
Is Dengue Vaccine Protection Possible?
inferred← citeshttps://doi.org/10.1093/femspd/ftz003openalex-snapshot
Focused dengue vaccine development: outwitting nature's design
inferred← citeshttps://doi.org/10.1093/gbe/evag045openalex-snapshot
Genomic Characterization of Dengue Virus in the Ningxia Hui Autonomous Region, China (2019 and 2023)
inferred← citeshttps://doi.org/10.1093/infdis/jiaa346openalex-snapshot
Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine
inferred← citeshttps://doi.org/10.1093/infdis/jiab064openalex-snapshot
Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine
inferred← citeshttps://doi.org/10.1093/infdis/jiad193openalex-snapshot
A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures
inferred← citeshttps://doi.org/10.1093/infdis/jit119openalex-snapshot
Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics
inferred← citeshttps://doi.org/10.1093/infdis/jiv536openalex-snapshot
Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization
inferred← citeshttps://doi.org/10.1093/infdis/jiw576openalex-snapshot
Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals
inferred← citeshttps://doi.org/10.1093/infdis/jix464openalex-snapshot
Zika Virus Vaccine Development
inferred← citeshttps://doi.org/10.1093/infdis/jiy063openalex-snapshot
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate
inferred← citeshttps://doi.org/10.1093/infdis/jiz109openalex-snapshot
Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
inferred← citeshttps://doi.org/10.1093/jme/tjab030openalex-snapshot
Current Effector and Gene-Drive Developments to Engineer Arbovirus-Resistant Aedes aegypti (Diptera: Culicidae) for a Sustainable Population Replacement Strategy in the Field
inferred← citeshttps://doi.org/10.1097/qco.0000000000000016openalex-snapshot
New opportunities for control of dengue virus
inferred← citeshttps://doi.org/10.1097/qco.0b013e32835fb938openalex-snapshot
The pathogenesis of dengue
inferred← citeshttps://doi.org/10.1099/jgv.0.000635openalex-snapshot
Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity
inferred← citeshttps://doi.org/10.1099/jgv.0.000669openalex-snapshot
Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients
inferred← citeshttps://doi.org/10.1099/vir.0.000160openalex-snapshot
Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine
inferred← citeshttps://doi.org/10.1101/2022.11.02.514909openalex-snapshot
Human FcγRIIIa activation on splenic macrophages drives the in vivo pathogenesis of dengue disease
inferred← citeshttps://doi.org/10.1101/2024.04.30.24306574openalex-snapshot
Envelope-dimer epitope-like broadly protective antibodies against dengue in children following natural infection and vaccination
inferred← citeshttps://doi.org/10.1101/2024.09.12.612520openalex-snapshot
pr-independent biogenesis of infectious mature Zika virus particles
inferred← citeshttps://doi.org/10.1101/2025.07.21.665855openalex-snapshot
mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADE
inferred← citeshttps://doi.org/10.1101/565259openalex-snapshot
Afucosylated maternal anti-dengue IgGs are a biomarker for susceptibility to dengue disease in their infants
inferred← citeshttps://doi.org/10.1101/674424openalex-snapshot
Oligomeric state of the ZIKV E protein defines protective immune responses
inferred← citeshttps://doi.org/10.1101/cshperspect.a029371openalex-snapshot
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
inferred← citeshttps://doi.org/10.1111/imm.12323openalex-snapshot
A high‐throughput shotgun mutagenesis approach to mapping B‐cell antibody epitopes
inferred← citeshttps://doi.org/10.1111/nyas.12413openalex-snapshot
Developing a dengue vaccine: progress and future challenges
inferred← citeshttps://doi.org/10.1111/pbi.12869openalex-snapshot
Plant‐expressed Fc‐fusion protein tetravalent dengue vaccine with inherent adjuvant properties
inferred← citeshttps://doi.org/10.1111/pbi.13501openalex-snapshot
Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice
inferred← citeshttps://doi.org/10.1111/tra.12469openalex-snapshot
Beyond attachment: Roles of DC‐SIGN in dengue virus infection
inferred← citeshttps://doi.org/10.1126/sciadv.abg4084openalex-snapshot
Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies
inferred← citeshttps://doi.org/10.1126/science.aaa8651openalex-snapshot
Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
showing the first 200 of 388
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.